Physicians' Academy for Cardiovascular Education

HoFH: Prevalence and new treatments

3' education - Sep. 1, 2013 - Snapshot 2013 - Dr Kees Hovingh

Dr. Kees Hovingh, AMC, Amsterdam, reviews recent data on the prevalence, phenotype and novel treatment options for patients with Homozygous Familial Hypercholesterolaemia.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: